transsphenoidal surgery

PROCEDURE3 trials

Sponsors

Shanghai Jiao Tong University School of Medicine, NYU Langone Health, St. Joseph's Hospital and Medical Center, Phoenix

Conditions

AcromegalyPituitary Adenoma

Phase 2

Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas

Shanghai Jiao Tong University School of MedicineAcromegaly

Start: 2004-01-31End: 2010-12-31Target: 96Updated: 2009-10-12

Phase 4

Surgical Debulking of Pituitary Adenomas

CompletedNCT01371643

NYU Langone HealthPituitary Adenoma

Start: 2004-04-30End: 2011-12-31Updated: 2016-08-29

Unknown Phase

Transsphenoidal Extent of Resection Study

CompletedNCT02357498

St. Joseph's Hospital and Medical Center, PhoenixPituitary Adenoma

Start: 2015-02-01End: 2019-04-08Updated: 2019-11-25

Related Papers

Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER) Study

Journal of neurosurgery2019-04-15126 citations

MON-439 Evaluation of Surgical Resection Goal and Its Relationship to the Extent of Resection and Patient Outcomes in 221 Patients following Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas: Data from the TRANSSPHER Study

Journal of the Endocrine Society2019-04-01

Pituitary Gland Endocrine Outcomes from a Prospective Multicenter Study of Fully Endoscopic Transsphenoidal Surgery for Adults with Nonfunctioning Pituitary Adenomas

Journal of Neurological Surgery Part B Skull Base2019-02-01

Proposal and Validation of a Simple Grading Scale (TRANSSPHER Grade) for Predicting Gross Total Resection of Nonfunctioning Pituitary Macroadenomas After Transsphenoidal Surgery

Operative Neurosurgery2019-01-1145 citations

Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial.

2010-01-0872 citations